Skip to main content
. Author manuscript; available in PMC: 2022 Aug 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2021 Aug 15;87(5):1119–1127. doi: 10.1097/QAI.0000000000002699

Table 3.

Physical examination findings compatible with Kaposi sarcoma (KS) at the time of rapid case ascertainment among participants living with HIV diagnosed within 1 month with KS from 2016 to 2019.

Characteristic Median (IQR) or Percentage (N=241)

Lesions compatible with KS
 ≥ 50 skin lesions* 36%
 Percentage of lesions that are raised 55% (35%–75%)
 ≥ 1 lesion of tumor (≥ 20 mm) morphology 37%
 ≥ 1 lesion with ulceration 24%
  Largest diameter of ulceration (mm) 20 (14–45)
 ≥ 1 lesion with superinfection 19%
  Largest diameter of superinfection 30 (15–50)
 Median number of anatomic regions with KS** 4 (2–7)
 Lesion with the largest diameter (mm) 28 (15–50)
Edema
 Any edema present 77%
 Facial (including periorbital) 7.3%
 Upper extremity 0.4%
 Genital 21%
 Lower extremity 68%
 No. of anatomic regions with edema*** 2 (1 to 2)
*

The presence of ≥ 50 skin lesions, as compared to <50 skin lesions, was not associated with ACTG T1 stage, presence of visceral disease, or CD4 count ≥200.

**

Anatomic regions for KS include the head, oral cavity, neck, chest, abdomen, back, arms, legs, hands, feet, genitals and gluteals

***

Anatomic regions for edema include the face, genitals, arms, legs, hands and feet.

Measured as number of raised compared to flat lesions averaged across three representative areas